(Q39015925)

English

Featured article: autophagic activation with nimotuzumab enhanced chemosensitivity and radiosensitivity of esophageal squamous cell carcinoma

scientific article published on 13 March 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Featured article: autophagic activation with nimotuzumab enhanced chemosensitivity and radiosensitivity of esophageal squamous cell carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

0 references

esophageal squamous cell carcinoma

1 reference

based on heuristic

inferred from title

author name string

Haizhu Song

1

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Banzhou Pan

2

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Jun Yi

3

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Longbang Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

publication date

13 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Experimental Biology and Medicine

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

239

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

529-541

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Salvage chemotherapy with mitomycin C, ifosfamide, and cisplatin (MIC) for previously treated metastatic or recurrent esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Second-line combination chemotherapy with docetaxel and nedaplatin for Cisplatin-pretreated refractory metastatic/recurrent esophageal squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Diffuse EGFR staining is associated with reduced overall survival in locally advanced oesophageal squamous cell cancer

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Epidermal growth factor receptor expression correlates with histologic grade in resected esophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Biomarkers in lung oncology

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Lack of survival benefit after stereotactic radiosurgery boost for glioblastoma multiforme: randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for pat

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Eaten alive: a history of macroautophagy

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Autophagy in aging, disease and death: the true identity of a cell death impostor

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Nimotuzumab, an antitumor antibody that targets the epidermal growth factor receptor, blocks ligand binding while permitting the active receptor conformation

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Use of the humanized anti-epidermal growth factor receptor monoclonal antibody h-R3 in combination with radiotherapy in the treatment of locally advanced head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Treatment of high-grade glioma patients with the humanized anti-epidermal growth factor receptor (EGFR) antibody h-R3: report from a phase I/II trial.

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

EGFR inhibition prevents in vitro tumor growth of salivary adenoid cystic carcinoma

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

The overexpression of IGFBP-3 is involved in the chemosensitivity of esophageal squamous cell carcinoma cells to nimotuzumab combined with cisplatin

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32.

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Role of autophagy in cancer: management of metabolic stress

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Somatic mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR) abrogate EGFR-mediated radioprotection in non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

EGFR tyrosine kinase inhibition induces autophagy in cancer cells

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Roles of autophagy in cetuximab-mediated cancer therapy against EGFR.

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Radiosensitisation of U87MG brain tumours by anti-epidermal growth factor receptor monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Enhancement of the antitumor activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Bivalent binding by intermediate affinity of nimotuzumab: a contribution to explain antibody clinical profile

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Enhancement of antitumor activity of the anti-EGF receptor monoclonal antibody cetuximab/C225 by perifosine in PTEN-deficient cancer cells

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

The epidermal growth factor receptor antibody cetuximab induces autophagy in cancer cells by downregulating HIF-1alpha and Bcl-2 and activating the beclin 1/hVps34 complex

1 reference

https://api.crossref.org/works/10.1177%2F1535370214525315

21 January 2018

Identifiers

10.1177/1535370214525315

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39015925&oldid=1802451314"